| 000 | 01623 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515002256.0 | ||
| 264 | 0 | _c20060106 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a0803-5253 | ||
| 024 | 7 |
_a10.1111/j.1651-2227.2005.tb02044.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJoergensen, J V | |
| 245 | 0 | 0 |
_aSevere hypothyroidism due to atrophic thyroiditis from second year of life influenced developmental outcome. _h[electronic resource] |
| 260 |
_bActa paediatrica (Oslo, Norway : 1992) _cAug 2005 |
||
| 300 |
_a1049-54 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAtrophy _xpathology |
| 650 | 0 | 4 | _aBiopsy, Needle |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDevelopmental Disabilities _xetiology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGrowth Disorders _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypothyroidism _xdrug therapy |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aThyroid Function Tests |
| 650 | 0 | 4 |
_aThyroiditis, Autoimmune _xcomplications |
| 650 | 0 | 4 |
_aThyroxine _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aOerbeck, B | |
| 700 | 1 | _aJebsen, P | |
| 700 | 1 | _aHeyerdahl, S | |
| 700 | 1 | _aKase, B F | |
| 773 | 0 |
_tActa paediatrica (Oslo, Norway : 1992) _gvol. 94 _gno. 8 _gp. 1049-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1651-2227.2005.tb02044.x _zAvailable from publisher's website |
| 999 |
_c15820071 _d15820071 |
||